Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.36	13.18	12.76
Graham Fair Price	147.28	3.56	1.44
PEG	-96.98	0.02	-0.73
Price/Book	7.93	1.53	1.42
Price/Cash Flow	325.74	82.80	19.45
Prices/Earnings	-82.44	11.81	67.23
Price/Sales	14.29	2.19	1.91
Price/FCF	325.74	82.80	19.45
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.49	0.20	0.21
Operating Margin	-3.77	0.13	0.13
ROA	520.73	< 0.005	< 0.005
ROE	< 0.005	0.03	514.46
ROIC	0.02	0.02	17.81
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.06	-72.19
Dividends QOQ	< 0.005	< 0.005	-46.58
EBIT QOQ	-0.20	-0.10	51.19
EPS QOQ	-0.92	5.36	482.10
FCF QOQ	-0.03	-0.75	-2359.31
Revenue QOQ	-0.02	-0.06	-195.35
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	49.70	55.97	12.61
Days Sales Outstanding (DSO)	44.91	55.07	22.62
Inventory Turnover	1.81	1.61	-11.20
Debt/Capitalization	0.47	0.48	1.21
Quick Ratio	0.63	0.75	18.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.17	4.16	-0.24
Cash	1.70	1.92	12.91
Capex	-0.25	-0.22	12.02
Free Cash Flow	0.30	0.08	-74.71
Revenue	3.10	2.92	-5.79
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.21	1.23	1.86
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	3.34	3.08	-7.71
Naive Interpretation	Member

06 - Financial Health · Weak

Rating